Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699206 | Clinical Oncology | 2011 | 7 Pages |
Abstract
At least a 3 year follow-up is required to accurately assess the outcome. The best effects of the treatment are achieved for small (<3Â cm), low-grade lesions with a low AVM score. The bleeding risk after stereotactic radiosurgery gradually decreases.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Blamek, R. Tarnawski, L. Miszczyk,